Formulation and Evaluation of Verapamil Solid Dispersion Tablets for Solubility Enhancement
DOI:
https://doi.org/10.37591/(rrjops).v7i1.514Abstract
This study was mainly designed to solve the drawbacks of conventional verapamil solid dosage form, low bioavailability and limited clinical efficacy, by preparing solid dispersion. Verapamil solid dispersion was developed by kneading method, melt solvent method and co-precipitation method to modify the release and enhance solubility of the drug. The physical state of the dispersed verapamil in the polymer matrix was characterized by differential scanning calorimetry, powder X-ray diffraction, scanning electron microscopy, Fourier-transform infrared spectroscopy, super saturation solubility testing and dissolution studies. Verapamil solid dispersions (FT 9) were formulated into tablets by direct compression method. On comparing with pure drug and physical mixture, the dissolution of verapamil solid dispersion was enhanced dramatically. Formulation FT 9 showed faster drug release in comparison to other formulations and marketed tablet. Formulation FT 9 follows first order kinetics and the release mechanism is super case II transport mechanism. The results of accelerated stability study indicated that there was no significant change in the tablets. The present study conclusively indicated that the use of various solid dispersion methods by using water soluble carriers improved the solubility of poorly water soluble drug.
Keywords: Solid dispersion, Verapamil, tablets, solubility enhancement
Cite this Article
Arun Raj R, Das Anju C, Sreerekha S, et al. Formulation and Evaluation of Verapamil Solid Dispersion Tablets for Solubility Enhancement. Research and Reviews: A Journal of Pharmaceutical Science. 2016; 7(1): 39–54p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |